PLASMA Act

H.R. 6465, Preserving Life-Saving Access to Specialty Medicines in America Act (Plasma Act), legislation to provide rebate phase-in for plasma- derived therapies under the Medicare Part D program. H.R. 5818, Medicare IVIG Access Enhancement Act of 2023. H.R. 4438, John W. Walsh Alpha-1 Home Infusion Act of 2023.

Client expense: Not reported · Firm income: $80,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Education regarding H.R.6465-Preserving Life-saving Access to Specialty Medicines in America Act (PLASMA Act) Issues related to the Medicaid Drug Rebate Program proposed rule, gene therapies, and value-based payment arrangements. Education on issues related to plasma derived products and inflation penalties related to drug shortages. Education on tax policies specific to the biopharmaceutical industry.

Client expense: $330,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

340B Program/Transparency; generics access; Clinical Trial Diversity S. 1114, Expanding Access to Low-Cost Generics Act To amend the Federal Food, Drug, and Cosmetic Act with respect to the 180-day exclusivity period. Sponsor: Sen. Smith, Tina [D-MN] S. 2305 - Biosimilar Red Tape Elimination Act To improve the requirements for making a determination of interchangeability of a biological product and its reference product. Sponsor: Sen. Lee, Mike [R-UT] S. 127 - Pharmacy Benefit Manager Transparency Act of 2023 To prevent unfair and deceptive acts or practices and the dissemination of false information related to pharmacy benefit management services for prescription drugs, and for other purposes. Sponsor: Sen. Cantwell, Maria [D-WA] S. 148 - Stop STALLING Act A bill to enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition, and facilitate the efficient review of petitions filed in good faith to raise legitimate public health concerns, and for other purposes. Sponsor: Sen. Amy Klobuchar (D-MN) S.1339 - Pharmacy Benefit Manager Reform Act To provide for increased oversight of entities that provide pharmacy benefit management services on behalf of group health plans and health insurance coverage. Sponsor: Sen. Sanders, Bernard [I-VT] S. 775, Increasing Transparency in Generic Drug Applications To provide for increased transparency in generic drug applications. Sponsor: Sen. Hassan, Margaret Wood [D-NH] H.R.3839 - To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. Sponsor: Rep. Dunn, Neal P. [R-FL-2] H.R. 9070, Affordable Prescriptions for Patients Act of 2024 To amend title 35, United States Code, to prohibit product hopping, and for other purposes. Sponsor: Rep. Issa, Darrell [R-CA-48] S. 150 - Affordable Prescriptions for Patients Act of 2023 To amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes. Sponsor: Sen. Cornyn, John [R-TX] S.1542, DRUG Act To improve services provided by pharmacy benefit managers. Sponsor: Sen. Marshall, Roger [R-KS] H.R.6094 - Providing Realistic Opportunity To Equal and Comparable Treatment (PROTECT) for Rare Act To amend titles XVIII and XIX of the Social Security Act and title XXVII of the Public Health Service Act to refine the set of information sources for determining coverage of certain drugs and biologicals used in the treatment or management of a rare disease or condition, and for other purposes. Sponsor: Rep. Matsui, Doris O. [D-CA-7] S. 142 - Preserve Access to Affordable Generics and Biosimilars Act To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products. Sponsor: Sen. Klobuchar, Amy [D-MN] S.2666 - EPCS 2.0 Act To amend the Public Health Service Act, the Employee Retirement Income Security Act of 1974, and the Internal Revenue Code of 1986 to provide for requirements for electronic-prescribing for controlled substances under group health plans and group and individual health insurance coverage. Sponsor: Sen. Hassan, Margaret Wood [D-NH] H.R.7312 - EPCS 2.0 Act To provide for requirements for electronic-prescribing for controlled substances under group health plans and group and individual health insurance coverage. Sponsor: Rep. Kuster, Ann M. [D-NH-2] S.4741 - PLASMA Act To amend title XVIII of the Social Security Act to provide a phase-in for plasma-derived products under the manufacturer discount program. Sponsor: Sen. Tillis, Thomas [R-NC] HR 6465 PLASMA Act To amend title XVIII of the Social Security Act to provide a phase-in for plasma-derived products under the manufacturer discount program. Sponsor: Rep. Hudson, Richard [R-NC-9] S. 1067, Ensuring Timely Access to Generics Act To amend the Federal Food, Drug, and Cosmetic Act with respect to citizen petitions. Sponsor: Sen. Shaheen, Jeanne [D-NH] H.R.1359 - Modernizing Opioid Treatment Access Act To expand the take-home prescribing of methadone through pharmacies. Sponsor: Rep. Norcross, Donald [D-NJ-1] S.644 - Modernizing Opioid Treatment Access Act To expand the take-home prescribing of methadone through pharmacies. Sponsor: Sen. Markey, Edward J. [D-MA]

Client expense: $1,760,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

Issues related to plasma therapies. H.R. 6465 / S.4741, Preserving Life-saving Access to Specialty Medicines in America (PLASMA) Act. Issues related to gene therapies. H.R. 2666, the Medicaid VBPs for Patients (MVP) Act and issues related to value-based payments. Issues related to drug shortages. Issues related to the Medicaid Drug Rebate Program. Monitored implementation of P.L. 117-169, the Inflation Reduction Act, as it relates to plasma derived products and drug pricing. Monitored issues related to pharmacy benefit management.

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 6465 & S. 4741, Preserving Life-Saving Access to Specialty Medicines in America Act (Plasma Act), legislation to provide rebate phase-in for plasma-derived therapies under the Medicare Part D program. H.R. 5818, Medicare IVIG Access Enhancement Act of 2023. H.R. 4438, John W. Walsh Alpha-1 Home Infusion Act of 2023.

Client expense: $410,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Legislative and regulatory issues related to gene therapies for hemophilia B; Issues related to plasma and plasma derived therapies; Issues related to H.R. 6465/S. 4741 - Preserving Life-saving Access to Specialty Medicines in America Act.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to Rx pricing; Issues related to plasma and plasma derived therapies; Issues related to H.R. 6465/S. 4741 - Preserving Life-saving Access to Specialty Medicines in America Act.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to Rx pricing; Issues related to plasma and plasma derived therapies; Issues related to H.R. 6465/S. 4741 - Preserving Life-saving Access to Specialty Medicines in America Act.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

340B Program/Transparency; generics access; Clinical Trial Diversity S. 1114, Expanding Access to Low-Cost Generics Act To amend the Federal Food, Drug, and Cosmetic Act with respect to the 180-day exclusivity period. Sponsor: Sen. Smith, Tina [D-MN] S. 2305 - Biosimilar Red Tape Elimination Act To improve the requirements for making a determination of interchangeability of a biological product and its reference product. Sponsor: Sen. Lee, Mike [R-UT] S. 127 - Pharmacy Benefit Manager Transparency Act of 2023 To prevent unfair and deceptive acts or practices and the dissemination of false information related to pharmacy benefit management services for prescription drugs, and for other purposes. Sponsor: Sen. Cantwell, Maria [D-WA] S. 148 - Stop STALLING Act A bill to enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition, and facilitate the efficient review of petitions filed in good faith to raise legitimate public health concerns, and for other purposes. Sponsor: Sen. Amy Klobuchar (D-MN) S.1339 - Pharmacy Benefit Manager Reform Act To provide for increased oversight of entities that provide pharmacy benefit management services on behalf of group health plans and health insurance coverage. Sponsor: Sen. Sanders, Bernard [I-VT] S. 775, Increasing Transparency in Generic Drug Applications To provide for increased transparency in generic drug applications. Sponsor: Sen. Hassan, Margaret Wood [D-NH] H.R.3839 - To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. Sponsor: Rep. Dunn, Neal P. [R-FL-2] H.R. 9070, Affordable Prescriptions for Patients Act of 2024 To amend title 35, United States Code, to prohibit product hopping, and for other purposes. Sponsor: Rep. Issa, Darrell [R-CA-48] S. 150 - Affordable Prescriptions for Patients Act of 2023 To amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes. Sponsor: Sen. Cornyn, John [R-TX] S.1542, DRUG Act To improve services provided by pharmacy benefit managers. Sponsor: Sen. Marshall, Roger [R-KS] H.R.6094 - Providing Realistic Opportunity To Equal and Comparable Treatment (PROTECT) for Rare Act To amend titles XVIII and XIX of the Social Security Act and title XXVII of the Public Health Service Act to refine the set of information sources for determining coverage of certain drugs and biologicals used in the treatment or management of a rare disease or condition, and for other purposes. Sponsor: Rep. Matsui, Doris O. [D-CA-7] S. 142 - Preserve Access to Affordable Generics and Biosimilars Act To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products. Sponsor: Sen. Klobuchar, Amy [D-MN] S.2666 - EPCS 2.0 Act To amend the Public Health Service Act, the Employee Retirement Income Security Act of 1974, and the Internal Revenue Code of 1986 to provide for requirements for electronic-prescribing for controlled substances under group health plans and group and individual health insurance coverage. Sponsor: Sen. Hassan, Margaret Wood [D-NH] H.R.7312 - EPCS 2.0 Act To provide for requirements for electronic-prescribing for controlled substances under group health plans and group and individual health insurance coverage. Sponsor: Rep. Kuster, Ann M. [D-NH-2] S.4741 - PLASMA Act To amend title XVIII of the Social Security Act to provide a phase-in for plasma-derived products under the manufacturer discount program. Sponsor: Sen. Tillis, Thomas [R-NC] HR 6465 PLASMA Act To amend title XVIII of the Social Security Act to provide a phase-in for plasma-derived products under the manufacturer discount program. Sponsor: Rep. Hudson, Richard [R-NC-9] S. 1067, Ensuring Timely Access to Generics Act To amend the Federal Food, Drug, and Cosmetic Act with respect to citizen petitions. Sponsor: Sen. Shaheen, Jeanne [D-NH] H.R.1359 - Modernizing Opioid Treatment Access Act To expand the take-home prescribing of methadone through pharmacies. Sponsor: Rep. Norcross, Donald [D-NJ-1] S.644 - Modernizing Opioid Treatment Access Act To expand the take-home prescribing of methadone through pharmacies. Sponsor: Sen. Markey, Edward J. [D-MA]

Client expense: $10,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

340B Program/Transparency; generics access; Clinical Trial Diversity S. 1114, Expanding Access to Low-Cost Generics Act To amend the Federal Food, Drug, and Cosmetic Act with respect to the 180-day exclusivity period. Sponsor: Sen. Smith, Tina [D-MN] S. 2305 - Biosimilar Red Tape Elimination Act To improve the requirements for making a determination of interchangeability of a biological product and its reference product. Sponsor: Sen. Lee, Mike [R-UT] S. 127 - Pharmacy Benefit Manager Transparency Act of 2023 To prevent unfair and deceptive acts or practices and the dissemination of false information related to pharmacy benefit management services for prescription drugs, and for other purposes. Sponsor: Sen. Cantwell, Maria [D-WA] S. 148 - Stop STALLING Act A bill to enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition, and facilitate the efficient review of petitions filed in good faith to raise legitimate public health concerns, and for other purposes. Sponsor: Sen. Amy Klobuchar (D-MN) S.1339 - Pharmacy Benefit Manager Reform Act To provide for increased oversight of entities that provide pharmacy benefit management services on behalf of group health plans and health insurance coverage. Sponsor: Sen. Sanders, Bernard [I-VT] S. 775, Increasing Transparency in Generic Drug Applications To provide for increased transparency in generic drug applications. Sponsor: Sen. Hassan, Margaret Wood [D-NH] H.R.3839 - To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. Sponsor: Rep. Dunn, Neal P. [R-FL-2] H.R. 9070, Affordable Prescriptions for Patients Act of 2024 To amend title 35, United States Code, to prohibit product hopping, and for other purposes. Sponsor: Rep. Issa, Darrell [R-CA-48] S. 150 - Affordable Prescriptions for Patients Act of 2023 To amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes. Sponsor: Sen. Cornyn, John [R-TX] S.1542, DRUG Act To improve services provided by pharmacy benefit managers. Sponsor: Sen. Marshall, Roger [R-KS] H.R.6094 - Providing Realistic Opportunity To Equal and Comparable Treatment (PROTECT) for Rare Act To amend titles XVIII and XIX of the Social Security Act and title XXVII of the Public Health Service Act to refine the set of information sources for determining coverage of certain drugs and biologicals used in the treatment or management of a rare disease or condition, and for other purposes. Sponsor: Rep. Matsui, Doris O. [D-CA-7] S. 142 - Preserve Access to Affordable Generics and Biosimilars Act To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products. Sponsor: Sen. Klobuchar, Amy [D-MN] S.2666 - EPCS 2.0 Act To amend the Public Health Service Act, the Employee Retirement Income Security Act of 1974, and the Internal Revenue Code of 1986 to provide for requirements for electronic-prescribing for controlled substances under group health plans and group and individual health insurance coverage. Sponsor: Sen. Hassan, Margaret Wood [D-NH] H.R.7312 - EPCS 2.0 Act To provide for requirements for electronic-prescribing for controlled substances under group health plans and group and individual health insurance coverage. Sponsor: Rep. Kuster, Ann M. [D-NH-2] S.4741 - PLASMA Act To amend title XVIII of the Social Security Act to provide a phase-in for plasma-derived products under the manufacturer discount program. Sponsor: Sen. Tillis, Thomas [R-NC] HR 6465 PLASMA Act To amend title XVIII of the Social Security Act to provide a phase-in for plasma-derived products under the manufacturer discount program. Sponsor: Rep. Hudson, Richard [R-NC-9] S. 1067, Ensuring Timely Access to Generics Act To amend the Federal Food, Drug, and Cosmetic Act with respect to citizen petitions. Sponsor: Sen. Shaheen, Jeanne [D-NH] H.R.1359 - Modernizing Opioid Treatment Access Act To expand the take-home prescribing of methadone through pharmacies. Sponsor: Rep. Norcross, Donald [D-NJ-1] S.644 - Modernizing Opioid Treatment Access Act To expand the take-home prescribing of methadone through pharmacies. Sponsor: Sen. Markey, Edward J. [D-MA]

Client expense: $140,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

Issues related to access to plasma-derived products and implementation of the Inflation Reduction Act (IRA, P. L. 117-169), including the Preserving Life-saving Access to Specialty Medicines in America (PLASMA) Act (H.R. 6465 / S. 4741, 118th Congress).

Client expense: Not reported · Firm income: $80,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

The PLASMA Act (H.R. 6465): Issues related to Part D and plasma-derived therapies.

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

The PLASMA Act (H.R. 6465): Issues related to Part D and plasma-derived therapies.

Client expense: Not reported · Firm income: Not reported

Medicare Part B provisions relating to home infusion of IVIG, particularly in CIPD and H.R. 3808. CMS programs relating to reference pricing systems. Issues relating to Source plasma donation and plasma protein products. The Inflation Reduction Act and provisions relating to plasma derived therapies and drug pricing including Part D rebates and HR 6465, The PLASMA Act.

Client expense: $130,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Education regarding H.R.6465-Preserving Life-saving Access to Specialty Medicines in America Act (PLASMA Act) Issues related to the Medicaid Drug Rebate Program proposed rule, gene therapies, and value-based payment arrangements. Education on issues related to plasma derived products and inflation penalties related to drug shortages. Education on tax policies specific to the biopharmaceutical industry.

Client expense: $370,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to plasma therapies. H.R. 6465 / S.4741, Preserving Life-saving Access to Specialty Medicines in America (PLASMA) Act. Issues related to gene therapies. H.R. 2666, the Medicaid VBPs for Patients (MVP) Act and issues related to value-based payments. Issues related to drug shortages. Issues related to the Medicaid Drug Rebate Program. Monitored implementation of P.L. 117-169, the Inflation Reduction Act, as it relates to plasma derived products and drug pricing. Monitored issues related to pharmacy benefit management.

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

PLASMA Act (S.4741/H.R.6465)

Client expense: Not reported · Firm income: $40,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Affordable Care Act (ACA), ACA subsidies and tax credits; Telehealth/ telehealth flexibilities; Mental Health Care; Youth Mental Health; Site neutral payment reform; hospital billing; Transparency in coverage; Surprise Billing; Prior Authorization; Hospital Consolidation; Health Equity Index reward factor; Employer-provided health coverage; Cybersecurity; Provider Directories; Artificial Intelligence; Health Equity; Maternal Health; Healthcare fraud; Food as Medicine; Mental Health Parity S. 1451 Healthy Competition for Better Care Act To ban anticompetitive terms in facility and insurance contracts that limit access to higher quality, lower cost care. Sponsor: Sen. Braun, Mike [R-IN] S. 3548 Health Care PRICE Transparency Act To amend the Public Health Service Act to provide for hospital and insurer price transparency. Sponsor: Sen. Braun, Mike [R-IN] H.R. 4818, Treat and Reduce Obesity Act To amend title XVIII of the Social Security Act to provide for the coordination of programs to prevent and treat obesity, and for other purposes. Sponsor: Rep. Wenstrup, Brad R. [R-OH-2] S.2407 - Treat and Reduce Obesity Act of 2023 To amend title XVIII of the Social Security Act to provide for the coordination of programs to prevent and treat obesity, and for other purposes. Sponsor: Sen. Carper, Thomas R. [D-DE] H.R.2630 - Safe Step Act To amend the Employee Retirement Income Security Act of 1974 to require a group health plan or health insurance coverage offered in connection with such a plan to provide an exceptions process for any medication step therapy protocol, and for other purposes. Sponsor: Rep. Wenstrup, Brad R. [R-OH-2] S.652 - Safe Step Act To amend the Employee Retirement Income Security Act of 1974 to require a group health plan or health insurance coverage offered in connection with such a plan to provide an exceptions process for any medication step therapy protocol, and for other purposes. Sponsor: Sen. Murkowski, Lisa [R-AK] S. 1001 Telehealth Expansion Act of 2023 To amend the Internal Revenue Code of 1986 to permanently extend the exemption for telehealth services from certain high deductible health plan rules. Sponsor: Sen. Daines, Steve [R-MT] H.R. 6487 - No Fees for EFTs Act To amend title XI of the Social Security Act to prohibit health plans from imposing fees on health care providers for electronic funds transfers and health care payment and remittance advice transactions, and for other purposes. Sponsor: Rep. Murphy, Gregory F. [R-NC-3] H.R. 1843 - Telehealth Expansion Act To amend the Internal Revenue Code of 1986 to permanently extend the exemption for telehealth services from certain high deductible health plan rules. Sponsor: Rep. Steel, Michelle [R-CA-45] H.R.3120 - Healthy Competition for Better Care Act To ban anticompetitive terms in facility and insurance contracts that limit access to higher quality, lower cost care. Sponsor: Rep. Steel, Michelle [R-CA-45] H.R. 4093, Remote Opioid Monitoring Act (House only) To provide for a study on the effects of remote monitoring on individuals who are prescribed opioids. Sponsor: Rep. Balderson, Troy [R-OH-12] H.R. 3305, Black Maternal Health Momnibus Act To end preventable maternal mortality, severe maternal morbidity, and maternal health disparities in the United States, and for other purposes. Sponsor: Rep. Underwood, Lauren [D-IL-14] S.2556 - Improving CARE for Youth Act To amend title XIX of the Social Security Act to ensure Medicaid coverage of mental health services and primary care services furnished on the same day. Sponsor: Sen. Carper, Thomas R. [D-DE] H.R.3226 - PREEMIE Reauthorization Act of 2023 To reauthorize the Prematurity Research Expansion and Education for Mothers who deliver Infants Early Act. Sponsor: Rep. Eshoo, Anna G. [D-CA-16] H.R.3838 - Preventing Maternal Deaths Reauthorization Act of 2023 To amend title III of the Public Health Service Act to reauthorize Federal support of States in their work to save and sustain the health of mothers during pregnancy, childbirth, and the postpartum period, to eliminate disparities in maternal health outcomes for pregnancy-related and pregnancy-associated deaths, to identify solutions to improve health care quality and health outcomes for mothers, and for other purposes. Sponsor: Rep. Burgess, Michael C. [R-TX-26] S.1869 - SITE Act To amend title XVIII of the Social Security Act and title XXVII of the Public Health Service Act to ensure fair billing practice for items and services furnished by off-campus hospital locations, to amend such title XVIII to provide for payments for graduate nursing education costs, and for other purposes. Sponsor: Sen. Braun, Mike [R-IN] H.R.3417 - FAIR Act To ensure fair billing practices for items and services furnished by off-campus outpatient departments of a provider. Sponsor: Rep. Hern, Kevin [R-OK-1] H.R. 5378 Lower Costs, More Transparency Act To promote price transparency in the health care sector, and for other purposes. Sponsor: Rep. McMorris Rodgers, Cathy [R-WA-5] H.R.4531 - Support for Patients and Communities Reauthorization Act To reauthorize certain programs that provide for opioid use disorder prevention, recovery, and treatment, and for other purposes. Sponsor: Rep. Guthrie, Brett [R-KY-2] H.R.3630 - No Surprises Act To amend title XXVII of the Public Health Service Act to protect health care consumers from surprise billing practices, and for other purposes. Sponsor: Rep. Pallone, Frank, Jr. [D-NJ-6] S.2016 - CONNECT for Health Act of 2023 To amend title XVIII of the Social Security Act to expand access to telehealth services, and for other purposes. Sponsor: Sen. Schatz, Brian [D-HI] H.R. 4189, CONNECT for Health Act To amend title XVIII of the Social Security Act to expand access to telehealth services, and for other purposes. Sponsor: Rep. Thompson, Mike [D-CA-4] HR 6465 PLASMA Act To amend title XVIII of the Social Security Act to provide a phase-in for plasma-derived products under the manufacturer discount program. Sponsor: Rep. Hudson, Richard [R-NC-9] H.R. 5012, SHINE for Autumn Act To improve research and data collection on stillbirths, and for other purposes. Sponsor: Rep. Kim, Young [R-CA-40] H.R. 6033, SPEAK Act To require the Secretary of Health and Human Services to establish a task force to improve access to health care information technology for non-English speakers. Sponsor: Rep. Steel, Michelle [R-CA-45] H.R. 4581, Maternal and Child Health Stillbirth Prevention Act To amend title V of the Social Security Act to support stillbirth prevention and research, and for other purposes. Sponsor: Rep. Hinson, Ashley [R-IA-2] S. 3430, Better Mental Health Care, Lower Cost Drugs, and Extenders Act To amend titles XVIII and XIX of the Social Security Act to expand the mental health care workforce and services, reduce prescription drug costs, and extend certain expiring provisions under Medicare and Medicaid, and for other purposes. Sponsor: Sen. Wyden, Ron [D-OR] H.R. 5066, Tech to Save Moms Act To amend the Public Health Service Act to authorize grants to evaluate, develop, and expand the use of technology-enabled collaborative learning and capacity building models to improve maternal health outcomes, and for other purposes. Sponsor: Rep. Williams, Nikema [D-GA-5]

Client expense: $1,910,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Office of Management & Budget (OMB), SENATE, White House Office

ACA subsidies and tax credits; Mental Health Care; hospital billing; Transparency in coverage; Hospital Consolidation; Health Equity Index; Cybersecurity; Provider Directories; Artificial Intelligence; Health Equity; Healthcare fraud; Food as Medicine; Mental Health Parity H.R. 6487 - No Fees for EFTs Act To amend title XI of the Social Security Act to prohibit health plans from imposing fees on health care providers for electronic funds transfers and Health care payment and remittance advice transactions, and for other purposes. Sponsor: Rep. Murphy, Gregory F. [R-NC-3] H.R. 1843 - Telehealth Expansion Act To amend the Internal Revenue Code of 1986 to permanently extend the exemption for telehealth services from certain high deductible health plan rules. Sponsor: Rep. Steel, Michelle [R-CA-45] H.R.3120 - Healthy Competition for Better Care Act To ban anticompetitive terms in facility and insurance contracts that limit access to higher quality, lower cost care. Sponsor: Rep. Steel, Michelle [R-CA-45] H.R. 4093, Remote Opioid Monitoring Act (House only) To provide for a study on the effects of remote monitoring on individuals who are prescribed opioids. Sponsor: Rep. Balderson, Troy [R-OH-12] S.2556 - Improving CARE for Youth Act To amend title XIX of the Social Security Act to ensure Medicaid coverage of mental health services and primary care services furnished on the same day. Sponsor: Sen. Carper, Thomas R. [D-DE] H.R.3226 - PREEMIE Reauthorization Act of 2023 To reauthorize the Prematurity Research Expansion and Education for Mothers who deliver Infants Early Act. Sponsor: Rep. Eshoo, Anna G. [D-CA-16] H.R.3838 - Preventing Maternal Deaths Reauthorization Act of 2023 To amend title III of the Public Health Service Act to reauthorize Federal support of States in their work to save and sustain the health of mothers during pregnancy, childbirth, and the postpartum period, to eliminate disparities in maternal health outcomes for pregnancy-related and pregnancy associated deaths, to identify solutions to improve health care quality and health outcomes for mothers, and for other purposes. Sponsor: Rep. Burgess, Michael C. [R-TX-26] S. 1869 SITE Act To amend title XVIII of the Social Security Act and title XXVII of the Public Health Service Act to ensure fair billing practice for items and services furnished by off-campus hospital locations, to amend such title XVIII to provide for payments for graduate nursing education costs, and for other purposes. Sponsor: Sen. Braun, Mike [R-IN] H.R. 3417 - FAIR Act To ensure fair billing practices for items and services furnished by off-campus outpatient departments of a provider. Sponsor: Rep. Hem, Kevin [R-OK-1] H.R. 5378 Lower Costs, More Transparency Act To promote price transparency in the health care sector, and for other purposes. Sponsor: Rep. McMorris Rodgers, Cathy [R-WA-5] H.R.4531 - Support for Patients and Communities Reauthorization Act To reauthorize certain programs that provide for opioid use disorder prevention, recovery, and treatment, and for other purposes. Sponsor: Rep. Guthrie, Brett [R-KY-2] H.R.3630 - No Surprises Act To amend title XXVII of the Public Health Service Act to protect health care consumers from surprise billing practices, and for other purposes. Sponsor: Rep. Pallone, Frank, Jr. [D-NJ-6] S.2016 - CONNECT for Health Act of2023 To amend title XVIII of the Social Security Act to expand access to telehealth services, and for other purposes. Sponsor: Sen. Schatz, Brian [D-HI] H.R. 4189, CONNECT for Health Act To amend title XVIII of the Social Security Act to expand access to telehealth services, and for other purposes. Sponsor: Rep. Thompson, Mike [D-CA-4] HR 6465 PLASMA Act To amend title XVIII of the Social Security Act to provide a phase-in for plasma-derived products under the manufacturer discount program. Sponsor: Rep. Hudson, Richard [R-NC-9] H.R. 5012, SHINE for Autumn Act To improve research and data collection on stillbirths, and for other purposes. Sponsor: Rep. Kim, Young [R-CA-40] H.R. 6033, SPEAK Act To require the Secretary of Health and Human Services to establish a task force to improve access to health care information technology for non English speakers. Sponsor: Rep. Steel, Michelle [R-CA-45] H.R. 4581, Maternal and Child Health Stillbirth Prevention Act To amend title V of the Social Security Act to support stillbirth prevention and research, and for other purposes. Sponsor: Rep. Hinson, Ashley [R-IA-2] S. 3430, Better Mental Health Care, Lower Cost Drugs, and Extenders Act To amend titles XVIII and XIX of the Social Security Act to expand the mental health care workforce and services, reduce prescription drug costs, and extend certain expiring provisions under Medicare and Medicaid, and for other purposes. Sponsor: Sen. Wyden, Ron [D-OR] H.R. 5066, Tech to Save Moms Act To amend the Public Health Service Act to authorize grants to evaluate, develop, and expand the use of technology-enabled collaborative learning and capacity building models to improve maternal health outcomes, and for other purposes. Sponsor: Rep. Williams, Nikema [D-GA-5]

Client expense: $10,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to Rx pricing. Issues related to plasma and plasma derived therapies. Issues related to H.R. 6465/S.4741 - Preserving Life-saving Access to Specialty Medicines in America Act.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to legislative and regulatory issues related to gene therapies for hemophilia B. Issues related to plasma and plasma derived therapies. Issues related to H.R. 6465/S.4741 - Preserving Life-saving Access to Specialty Medicines in America Act.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to Rx pricing. Issues related to plasma and plasma derived therapies. Issues related to H.R. 6465/S.4741 - Preserving Life-saving Access to Specialty Medicines in America Act.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

ACA Subsidies and Tax Credits; Mental Health Care; Hospital Billing; Transparency in Coverage; Hospital Consolidation; Health Equity Index; Cybersecurity; Provider Directories; Artificial Intelligence; Health Equity; Health Care Fraud; Food as Medicine; Mental Health Parity HR 1843, Telehealth Expansion Act, by Rep. Michelle Steel (R-CA). To amend the Internal Revenue Code of 1986 to permanently extend the exemption for telehealth services from certain high deductible health plan rules. HR 3120, Healthy Competition for Better Care Act, by Rep. Michelle Steel (R-CA). To ban anticompetitive terms in facility and insurance contracts that limit access to higher quality, lower cost care. HR 3226, PREEMIE Reauthorization Act of 2023, by Rep. Anna Eshoo (D-CA). Reauthorizes through FY2028 and otherwise modifies research and education programs for preventing premature births. HR 3305, Black Maternal Health Momnibus Act, by Rep. Lauren Underwood (D-IL). To end preventable maternal mortality, severe maternal morbidity, and maternal health disparities in the United States. HR 3417, FAIR Act, by Rep. Kevin Hern (R-OK). To ensure fair billing practices for items and services furnished by off-campus outpatient departments of a provider. HR 3630, No Surprises Act, by Rep. Frank Pallone (D-NJ). To amend title XXVII of the Public Health Service Act to protect health care consumers from surprise billing practices. HR 3838, Preventing Maternal Deaths Reauthorization Act of 2023, by Rep. Michael Burgess (R-TX). To amend title III of the Public Health Service Act to reauthorize Federal support of States in their work to save and sustain the health of mothers during pregnancy, childbirth, and the postpartum period, to eliminate disparities in maternal health outcomes for pregnancy-related and pregnancy-associated deaths, to identify solutions to improve health care quality and health outcomes for mothers. HR 4093, Remote Opioid Monitoring, by Rep. Troy Balderson (R-OH). To provide for a study on the effects of remote monitoring on individuals who are prescribed opioids. HR 4189, CONNECT for Health Act, by Rep. Mike Thompson (D-CA). To amend title XVIII of the Social Security Act to expand access to telehealth services. HR 4531, Support for Patients and Communities Reauthorization Act, by Rep. Brett Guthrie (R-KY). To reauthorize certain programs that provide for opioid use disorder prevention, recovery, and treatment. HR 4581, Maternal and Child Health Stillbirth Prevention Act, by Rep. Ashley Hinson (R-IA). To amend title V of the Social Security Act to support stillbirth prevention and research, and for other purposes. HR 5012, SHINE for Autumn Act, by Rep. Young Kim (R-CA). To improve research and data collection on stillbirths. HR 5066, Tech to Save Moms Act, by Rep. Nikema Williams (D-GA). To amend the Public Health Service Act to authorize grants to evaluate, develop, and expand the use of technology-enabled collaborative learning and capacity building models to improve maternal health outcomes, and for other purposes. HR 5378, Lower Costs, More Transparency Act, by Rep. Cathy McMorris Rodgers (R-WA). To promote price transparency in the health care sector. HR 6033, SPEAK Act, by Rep. Michelle Steel (R-CA). To require the Secretary of Health and Human Services to establish a task force to improve access to health care information technology for non-English speakers. HR 6465, PLASMA Act, by Rep. Richard Hudson (R-NC). To amend title XVIII of the Social Security Act to provide a phase-in for plasma-derived products under the manufacturer discount program. HR 6487, No Fees for EFTs Act, by Rep. Gregory Murphy (R-NC). To amend title XI of the Social Security Act to prohibit health plans from imposing fees on health care providers for electronic funds transfers and health care payment and remittance advice transactions. S 1869, SITE Act, by Sen. Mike Braun (D-HI). To amend title XVIII of the Social Security Act and title XXVII of the Public Health Service Act to ensure fair billing practice for items and services furnished by off-campus hospital locations, to amend such title XVIII to provide for payments for graduate nursing education costs. S 2016, CONNECT for Health Act of 2023, by Sen. Brian Schatz (D-HI). To amend title XVIII of the Social Security Act to expand access to telehealth services. S 2556, Improving CARE for Youth Act, by Sen. Thomas Carper (D-DE). To amend title XIX of the Social Security Act to ensure Medicaid coverage of mental health services and primary care services furnished on the same day. S 3393, SUPPORT for Patients and Communities Reauthorization Act, by Sen. Bernie Sanders (I-VT). To reauthorize the SUPPORT for Patients and Communities Act, and for other purposes. S 3430, Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023, by Sen. Ron Wyden (D-OR). To amend titles XVIII and XIX of the Social Security Act to expand the mental health care workforce and services, reduce prescription drug costs, and extend certain expiring provisions under Medicare and Medicaid.

Client expense: $220,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Office of Management & Budget (OMB), SENATE, White House Office

Issues related to access to plasma-derived products and implementation of the Inflation Reduction Act (IRA, P. L. 117-169), including the Preserving Life-saving Access to Specialty Medicines in America (PLASMA) Act (H.R. 6465 / S. 4741).

Client expense: Not reported · Firm income: $70,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 6465, Preserving Life-Saving Access to Specialty Medicines in America Act (Plasma Act), legislation to provide rebate phase-in for plasma-derived therapies under the Medicare Part D program. H.R. 5818, Medicare IVIG Access Enhancement Act of 2023. H.R. 4438, John W. Walsh Alpha-1 Home Infusion Act of 2023.

Client expense: $430,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Educational meetings on Grifols, presence in district/state, and unique cost considerations of plasma medicines; House and Senate meetings to advance HR 6465 to provide a phase-in for plasma therapies of the Medicare Part D catastrophic coverage rebate of 20% mandated under the Inflation Reduction Act. Meetings to advocate for home infusion coverage of plasma therapies for rare diseases such as Alpha-1 Antitrypsin Deficiency and Chronic Inflammatory Demyelinating Polyneuropathy. Meetings to advocate for Medicare coverage of IVIG to great primary immune deficiency in the skilled nursing facility setting.

Client expense: $160,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Educational meetings on Grifols, presence in district/state, and unique cost considerations of plasma medicines; House and Senate meetings to advance HR 6465 to provide a phase-in for plasma therapies of the Medicare Part D catastrophic coverage rebate of 20% mandated under the Inflation Reduction Act. Meetings to advocate for home infusion coverage of plasma therapies for rare diseases such as Alpha-1 Antitrypsin Deficiency and Chronic Inflammatory Demyelinating Polyneuropathy. Meetings to advocate for Medicare coverage of IVIG to great primary immune deficiency in the skilled nursing facility setting.

Client expense: $160,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Affordable Care Act (ACA), ACA subsidies and tax credits; Telehealth/ telehealth flexibilities; Mental Health Care; Youth Mental Health; Site neutral payment reform; hospital billing; Transparency in coverage; Surprise Billing; 2025 Proposed NBPP/Individual Market/ACA exchanges; Rural healthcare; Prior Authorization; Hospital Consolidation; Health Equity Index reward factor; Employer-provided health coverage; Cybersecurity; Provider Directories; Artificial Intelligence; Health Equity; Maternal Health; CMS Transforming Maternal Health (TMaH) model; Birthing-Friendly Designation; Preventive Services; Data Equity; Hospital Billing S.2556 - Improving CARE for Youth Act To amend title XIX of the Social Security Act to ensure Medicaid coverage of mental health services and primary care services furnished on the same day. Sponsor: Sen. Carper, Thomas R. [D-DE] H.R.3226 - PREEMIE Reauthorization Act of 2023 To reauthorize the Prematurity Research Expansion and Education for Mothers who deliver Infants Early Act. Sponsor: Rep. Eshoo, Anna G. [D-CA-16] H.R.3838 - Preventing Maternal Deaths Reauthorization Act of 2023 To amend title III of the Public Health Service Act to reauthorize Federal support of States in their work to save and sustain the health of mothers during pregnancy, childbirth, and the postpartum period, to eliminate disparities in maternal health outcomes for pregnancy-related and pregnancy-associated deaths, to identify solutions to improve health care quality and health outcomes for mothers, and for other purposes. Sponsor: Rep. Burgess, Michael C. [R-TX-26] S.1869 - SITE Act To amend title XVIII of the Social Security Act and title XXVII of the Public Health Service Act to ensure fair billing practice for items and services furnished by off-campus hospital locations, to amend such title XVIII to provide for payments for graduate nursing education costs, and for other purposes. Sponsor: Sen. Braun, Mike [R-IN] H.R.3417 - FAIR Act To ensure fair billing practices for items and services furnished by off-campus outpatient departments of a provider. Sponsor: Rep. Hern, Kevin [R-OK-1] H.R. 5378 Lower Costs, More Transparency Act To promote price transparency in the health care sector, and for other purposes. Sponsor: Rep. McMorris Rodgers, Cathy [R-WA-5] H.R.4531 - Support for Patients and Communities Reauthorization Act To reauthorize certain programs that provide for opioid use disorder prevention, recovery, and treatment, and for other purposes. Sponsor: Rep. Guthrie, Brett [R-KY-2] S.652 - Safe Step Act To amend the Employee Retirement Income Security Act of 1974 to require a group health plan or health insurance coverage offered in connection with such a plan to provide an exceptions process for any medication step therapy protocol, and for other purposes. Sponsor: Sen. Murkowski, Lisa [R-AK] S. 1001 Telehealth Expansion Act of 2023 To amend the Internal Revenue Code of 1986 to permanently extend the exemption for telehealth services from certain high deductible health plan rules. Sponsor: Sen. Daines, Steve [R-MT] H.R.3630 - No Surprises Act To amend title XXVII of the Public Health Service Act to protect health care consumers from surprise billing practices, and for other purposes. Sponsor: Rep. Pallone, Frank, Jr. [D-NJ-6] S. 3393 - SUPPORT for Patients and Communities Reauthorization Act To reauthorize the SUPPORT for Patients and Communities Act, and for other purposes. Sponsor: Sen. Sanders, Bernard [I-VT] S.2016 - CONNECT for Health Act of 2023 To amend title XVIII of the Social Security Act to expand access to telehealth services, and for other purposes. Sponsor: Sen. Schatz, Brian [D-HI] S. 1451 Healthy Competition for Better Care Act To ban anticompetitive terms in facility and insurance contracts that limit access to higher quality, lower cost care. Sponsor: Sen. Braun, Mike [R-IN] S.1606 - Black Maternal Health Momnibus Act To end preventable maternal mortality, severe maternal morbidity, and maternal health disparities in the United States, and for other purposes. Sponsor: Sen. Booker, Cory A. [D-NJ] H.R.7153 - Dr. Lorna Breen Health Care Provider Protection Reauthorization Act To reauthorize the Dr. Lorna Breen Health Care Provider Protection Act, and for other purposes. The Lorn Breen Act established grants and required other activities to improve mental and behavioral health among health care providers. Sponsor: Rep. Wild, Susan [D-PA-7] H.R.2923 - Living Donor Protection Act of 2023 To promote and protect from discrimination living organ donors. Sponsor: Rep. Nadler, Jerrold [D-NY-12] HR 6465 PLASMA Act To amend title XVIII of the Social Security Act to provide a phase-in for plasma-derived products under the manufacturer discount program. Sponsor: Rep. Hudson, Richard [R-NC-9] S.1573 - PREEMIE Reauthorization Act of 2023 To reauthorize the Prematurity Research Expansion and Education for Mothers who deliver Infants Early Act. "Sponsor: Sen. Bennet, Michael F. [D-CO]" S.2415 - Preventing Maternal Deaths Reauthorization Act of 2023 To amend title III of the Public Health Service Act to reauthorize Federal support of States in their work to save and sustain the health of mothers during pregnancy, childbirth, and the postpartum period, to eliminate disparities in maternal health outcomes for pregnancy-related and pregnancy-associated deaths, to identify solutions to improve health care quality and health outcomes for mothers, and for other purposes. Sponsor: Sen. Capito, Shelley Moore [R-WV] S. 3548 Health Care PRICE Transparency Act To amend the Public Health Service Act to provide for hospital and insurer price transparency. Sponsor: Sen. Braun, Mike [R-IN] H.R. 5012, SHINE for Autumn Act To improve research and data collection on stillbirths, and for other purposes. Sponsor: Rep. Kim, Young [R-CA-40] H.R. 6033, SPEAK Act To require the Secretary of Health and Human Services to establish a task force to improve access to health care information technology for non-English speakers. Sponsor: Rep. Steel, Michelle [R-CA-45] H.R. 4581, Maternal and Child Health Stillbirth Prevention Act To amend title V of the Social Security Act to support stillbirth prevention and research, and for other purposes. Sponsor: Rep. Hinson, Ashley [R-IA-2] S. 3430, Better Mental Health Care, Lower Cost Drugs, and Extenders Act To amend titles XVIII and XIX of the Social Security Act to expand the mental health care workforce and services, reduce prescription drug costs, and extend certain expiring provisions under Medicare and Medicaid, and for other purposes. Sponsor: Sen. Wyden, Ron [D-OR] H.R. 5066, Tech to Save Moms Act To amend the Public Health Service Act to authorize grants to evaluate, develop, and expand the use of technology-enabled collaborative learning and capacity building models to improve maternal health outcomes, and for other purposes. Sponsor: Rep. Williams, Nikema [D-GA-5] H.R. 4818, Treat and Reduce Obesity Act To amend title XVIII of the Social Security Act to provide for the coordination of programs to prevent and treat obesity, and for other purposes. Sponsor: Rep. Wenstrup, Brad R. [R-OH-2] S.3679 - Dr. Lorna Breen Health Care Provider Protection Reauthorization Act To reauthorize the Dr. Lorna Breen Health Care Provider Protection Act, and for other purposes. Sponsor: Sen. Kaine, Tim [D-VA]

Client expense: $1,430,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Office of Management & Budget (OMB), SENATE, White House Office

Education regarding H.R.6465-Preserving Life-saving Access to Specialty Medicines in America Act (PLASMA Act) Issues related to the Medicaid Drug Rebate Program proposed rule, gene therapies, and value-based payment arrangements. Education on issues related to plasma derived products and inflation penalties related to drug shortages.

Client expense: $360,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to plasma therapies. H.R. 6465, Preserving Life-saving Access to Specialty Medicines in America Act. Issues related to gene therapies. H.R. 2666, the Medicaid VBPs for Patients (MVP) Act and issues related to value-based payments. Issues related to drug shortages. Issues related to the Medicaid Drug Rebate Program. Monitored implementation of P.L. 117-169, the Inflation Reduction Act, as it relates to plasma derived products and drug pricing. Monitored issues related to pharmacy benefit management.

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicare Part B provisions relating to home infusion of IVIG, particularly in CIPD and H.R. 3808. CMS programs relating to reference pricing systems. Issues relating to Source plasma donation and plasma protein products. The Inflation Reduction Act and provisions relating to plasma derived therapies and drug pricing including Part D rebates and HR 6465, The PLASMA Act.

Client expense: $170,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Issues related to access to plasma-derived products and implementation of the Inflation Reduction Act (IRA, P. L. 117-169), including the Preserving Life-saving Access to Specialty Medicines in America (PLASMA) Act (H.R. 6465).

Client expense: Not reported · Firm income: $80,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 6465, Preserving Life-Saving Access to Specialty Medicines in America Act (Plasma Act), legislation to provide rebate phase-in for plasma-derived therapies under the Medicare Part D program. H.R. 5818, Medicare IVIG Access Enhancement Act of 2023. H.R. 4438, John W. Walsh Alpha-1 Home Infusion Act of 2023.

Client expense: $430,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to plasma derived products, including H.R.6465-Preserving Life-saving Access to Specialty Medicines in America Act (PLASMA Act).

Client expense: Not reported · Firm income: Not reported

Educational meetings on Grifols, presence in district/state, and unique cost considerations of plasma medicines; House and Senate meetings to advance HR 6465 to provide a phase-in for plasma therapies of the Medicare Part D catastrophic coverage rebate of 20% mandated under the Inflation Reduction Act. Meetings to advocate for home infusion coverage of plasma therapies for rare diseases such as Alpha-1 Antitrypsin Deficiency and Chronic Inflammatory Demyelinating Polyneuropathy. Meetings to advocate for Medicare coverage of IVIG to great primary immune deficiency in the skilled nursing facility setting.

Client expense: $160,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Education regarding H.R.6465-Preserving Life-saving Access to Specialty Medicines in America Act (PLASMA Act) Issues related to the Medicaid Drug Rebate Program proposed rule, gene therapies, and value-based payment arrangements. Education on issues related to plasma derived products and inflation penalties related to drug shortages.

Client expense: $260,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to gene therapy. Issues related to plasma therapies. H.R. 2666, the Medicaid VBPs for Patients (MVP) Act and issues related to value-based payment arrangements. Monitored implementation of P.L. 117-169, the Inflation Reduction Act, as it relates to plasma derived products and drug pricing. Monitored issues related to pharmacy benefit management. Issues related to drug shortages. Issues related to the Medicaid Drug Rebate Program. H.R.6465, PLASMA Act - Preserving Life-saving Access to Specialty Medicines in America Act.

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Affordable Care Act (ACA); ACA subsidies and tax credits; Telehealth & telehealth flexibilities; Mental Health Care; Youth Mental Health; Site neutral payment reform; Transparency in coverage; Surprise Billing; 2025 Proposed NBPP/Individual Market/ACA exchanges; Rural healthcare; Prior Authorization; Hospital Consolidation; Health Equity Index reward factor; Employer-provided health coverage; Cyber Attack; Birthing-Friendly Designation; Provider Directories; HIPAA Modernization; Artificial Intelligence S.2556 - Improving CARE for Youth Act To amend title XIX of the Social Security Act to ensure Medicaid coverage of mental health services and primary care services furnished on the same day. Sponsor: Sen. Carper, Thomas R. [D-DE] H.R.3226 - PREEMIE Reauthorization Act of 2023 To reauthorize the Prematurity Research Expansion and Education for Mothers who deliver Infants Early Act. Sponsor: Rep. Eshoo, Anna G. [D-CA-16] H.R.3838 - Preventing Maternal Deaths Reauthorization Act of 2023 To amend title III of the Public Health Service Act to reauthorize Federal support of States in their work to save and sustain the health of mothers during pregnancy, childbirth, and the postpartum period, to eliminate disparities in maternal health outcomes for pregnancy-related and pregnancy-associated deaths, to identify solutions to improve health care quality and health outcomes for mothers, and for other purposes. Sponsor: Rep. Burgess, Michael C. [R-TX-26] H.R.2708 - Latonya Reeves Freedom Act of 2023 To prohibit discrimination against individuals with disabilities who need long-term services and supports, and for other purposes. Sponsor: Rep. Cohen, Steve [D-TN-9] H.R.6412 - Down Syndrome Diagnosis Act To amend title XXVII of the Public Health Service Act to provide certain informational resources related to Down syndrome. Sponsor: Rep. Molinaro, Marcus J. [R-NY-19] S.1869 - SITE Act To amend title XVIII of the Social Security Act and title XXVII of the Public Health Service Act to ensure fair billing practice for items and services furnished by off-campus hospital locations, to amend such title XVIII to provide for payments for graduate nursing education costs, and for other purposes. Sponsor: Sen. Braun, Mike [R-IN] H.R.3417 - FAIR Act To ensure fair billing practices for items and services furnished by off-campus outpatient departments of a provider. Sponsor: Rep. Hern, Kevin [R-OK-1] H.R. 5378 Lower Costs, More Transparency Act To promote price transparency in the health care sector, and for other purposes. Sponsor: Rep. McMorris Rodgers, Cathy [R-WA-5] H.R.4531 - Support for Patients and Communities Reauthorization Act To reauthorize certain programs that provide for opioid use disorder prevention, recovery, and treatment, and for other purposes. Sponsor: Rep. Guthrie, Brett [R-KY-2] S.652 - Safe Step Act To amend the Employee Retirement Income Security Act of 1974 to require a group health plan or health insurance coverage offered in connection with such a plan to provide an exceptions process for any medication step therapy protocol, and for other purposes. Sponsor: Sen. Murkowski, Lisa [R-AK] S. 1001 Telehealth Expansion Act of 2023 To amend the Internal Revenue Code of 1986 to permanently extend the exemption for telehealth services from certain high deductible health plan rules. Sponsor: Sen. Daines, Steve [R-MT] H.R.3630 - No Surprises Act To amend title XXVII of the Public Health Service Act to protect health care consumers from surprise billing practices, and for other purposes. Sponsor: Rep. Pallone, Frank, Jr. [D-NJ-6] S. 3393 - SUPPORT for Patients and Communities Reauthorization Act To reauthorize the SUPPORT for Patients and Communities Act, and for other purposes. Sponsor: Sen. Sanders, Bernard [I-VT] S.2016 - CONNECT for Health Act of 2023 To amend title XVIII of the Social Security Act to expand access to telehealth services, and for other purposes. Sponsor: Sen. Schatz, Brian [D-HI] S. 1451 Healthy Competition for Better Care Act To ban anticompetitive terms in facility and insurance contracts that limit access to higher quality, lower cost care. Sponsor: Sen. Braun, Mike [R-IN] S.1606 - Black Maternal Health Momnibus Act To end preventable maternal mortality, severe maternal morbidity, and maternal health disparities in the United States, and for other purposes. Sponsor: Sen. Booker, Cory A. [D-NJ] H.R.7153 - Dr. Lorna Breen Health Care Provider Protection Reauthorization Act To reauthorize the Dr. Lorna Breen Health Care Provider Protection Act, and for other purposes. The Lorn Breen Act established grants and required other activities to improve mental and behavioral health among health care providers. Sponsor: Rep. Wild, Susan [D-PA-7] H.R.2923 - Living Donor Protection Act of 2023 To promote and protect from discrimination living organ donors. Sponsor: Rep. Nadler, Jerrold [D-NY-12] HR 6465 PLASMA Act To amend title XVIII of the Social Security Act to provide a phase-in for plasma-derived products under the manufacturer discount program. Sponsor: Rep. Hudson, Richard [R-NC-9]

Client expense: $1,940,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Office of Management & Budget (OMB), SENATE, White House Office

Medicare Part B provisions relating to home infusion of IVIG, particularly in CIPD and H.R. 3808. CMS programs relating to reference pricing systems. Issues relating to Source plasma donation and plasma protein products. The Inflation Reduction Act and provisions relating to plasma derived therapies and drug pricing including Part D rebates and HR 6465, The PLASMA Act.

Client expense: $190,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Issues related to access to plasma-derived products and implementation of the Inflation Reduction Act (IRA, P. L. 117-169), including the Preserving Life-saving Access to Specialty Medicines in America (PLASMA) Act (H.R. 6465).

Client expense: Not reported · Firm income: $70,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Education regarding H.R.6465-Preserving Life-saving Access to Specialty Medicines in America Act (PLASMA Act) Issues related to the Medicaid Drug Rebate Program proposed rule, gene therapies, and value-based payment arrangements. Education on issues related to plasma derived products and inflation penalties related to drug shortages.

Client expense: $260,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Educational meetings on Grifols, presence in district/state, and unique cost considerations of plasma medicines; House and Senate meetings to advance HR 6465 to provide a phase-in for plasma therapies of the Medicare Part D catastrophic coverage rebate of 20% mandated under the Inflation Reduction Act. Meetings to advocate for home infusion coverage of plasma therapies for rare diseases such as Alpha-1 Antitrypsin Deficiency and Chronic Inflammatory Demyelinating Polyneuropathy.

Client expense: $320,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

The Affordable Care Act, provisions relating to essential health benefits and patient protections. Medicare Part B provisions relating to home infusion of IVIG, particularly in CIPD and H.R. 3808. CMS programs relating to reference pricing systems. Issues relating to Source plasma donation and plasma protein products. The Inflation Reduction Act and provisions relating to plasma derived therapies and drug pricing including Part D rebates and HR 6465, The PLASMA Act.

Client expense: $120,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Issues related to access to plasma-derived products and implementation of the Inflation Reduction Act (IRA, P. L. 117-169), including the Preserving Life-saving Access to Specialty Medicines in America (PLASMA) Act (H.R. 6465).

Client expense: Not reported · Firm income: $80,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE